We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$178M
AUM Growth
+$108M
Cap. Flow
+$107M
Cap. Flow %
60.42%
Top 10 Hldgs %
3.93%
Holding
829
New
562
Increased
57
Reduced
34
Closed
175

Top Buys

Rank Stock Value
1
SFM icon
Sprouts Farmers Market
SFM
+$969K
2
TIGR
UP Fintech Holding
TIGR
+$737K
3
CAAP icon
Corporacion America
CAAP
+$729K
4
LX
LexinFintech Holdings
LX
+$728K
5
W icon
Wayfair
W
+$720K

Top Sells

Rank Stock Value
1
CRUS icon
Cirrus Logic
CRUS
+$563K
2
MNST icon
Monster Beverage
MNST
+$526K
3
CLX icon
Clorox
CLX
+$510K
4
OKTA icon
Okta
OKTA
+$488K
5
NDSN icon
Nordson
NDSN
+$480K

Sector Composition

Rank Sector Weight
1 Technology 15.42%
2 Healthcare 13.97%
3 Financials 13.71%
4 Consumer Discretionary 13.67%
5 Industrials 13.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAIL icon
251
FreightCar America
RAIL
$279M
$288K 0.16%
+29,447
New +$281K
SLNO
252
DELISTED
Soleno Therapeutics
SLNO
$288K 0.16%
+4,257
New +$316K
CTSH icon
253
Cognizant
CTSH
$22.3B
$287K 0.16%
+4,280
New +$309K
BMY icon
254
Bristol-Myers Squibb
BMY
$128B
$287K 0.16%
+6,358
New +$297K
PLMR icon
255
Palomar
PLMR
$3.73B
$286K 0.16%
+2,451
New +$311K
SDGR icon
256
Schrodinger
SDGR
$1.14B
$286K 0.16%
+14,254
New +$286K
REPX icon
257
Riley Exploration Permian
REPX
$740M
$285K 0.16%
+10,522
New +$288K
VNDA icon
258
Vanda Pharmaceuticals
VNDA
$314M
$285K 0.16%
+57,037
New +$264K
SKWD icon
259
Skyward Specialty Insurance
SKWD
$2.49B
$284K 0.16%
+5,980
New +$299K
ALIT icon
260
Alight
ALIT
$520M
$284K 0.16%
+4,358
New +$385K
LRCX icon
261
Lam Research
LRCX
$365B
$283K 0.16%
+2,116
New +$224K
CR icon
262
Crane Co
CR
$13.1B
$282K 0.16%
+1,533
New +$289K
ENVA icon
263
Enova International
ENVA
$6.27B
$282K 0.16%
+2,452
New +$280K
RITM icon
264
Rithm Capital
RITM
$5.15B
$281K 0.16%
24,669
+7,674
+45% +$93K
SBRA icon
265
Sabra Healthcare REIT
SBRA
$5.65B
$280K 0.16%
+15,025
New +$281K
JAKK icon
266
Jakks Pacific
JAKK
$297M
$279K 0.16%
+14,921
New +$274K
AMPX icon
267
Amprius Technologies
AMPX
$1.38B
$279K 0.16%
+26,558
New +$209K
BLKB icon
268
Blackbaud
BLKB
$1.59B
$279K 0.16%
+4,341
New +$284K
NGG icon
269
National Grid
NGG
$81.6B
$279K 0.16%
+3,895
New +$273K
CI icon
270
Cigna
CI
$77B
$279K 0.16%
+967
New +$286K
MAX icon
271
MediaAlpha
MAX
$734M
$279K 0.16%
+24,480
New +$270K
BAP icon
272
Credicorp
BAP
$31.1B
$278K 0.16%
+1,045
New +$259K
AVA icon
273
Avista
AVA
$3.43B
$278K 0.16%
7,340
-3,194
-30% -$119K
PG icon
274
Procter & Gamble
PG
$346B
$277K 0.16%
+1,803
New +$282K
NCNO icon
275
nCino
NCNO
$1.93B
$276K 0.16%
+10,195
New +$298K
9 10
11
12 13

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
AIA
Acute Investment Advisory Mesa, Arizona $8.91M AUM 4.28% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM

PharVision Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, PharVision Advisers held 829 positions worth $178M, up 155% from $69.6M the previous quarter. Its ten largest holdings account for 3.9% of the portfolio.

PharVision Advisers deployed $107M of net new capital in Q3 2025, opening 562 new positions and adding to 57 existing holdings. Its largest new stake was Sprouts Farmers Market: 6,658 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Western Union, an estimated $321K trimmed.

  • PharVision Advisers's largest Q3 2025 buy was Sprouts Farmers Market: 6,658 shares worth $724K.
  • PharVision Advisers added most to Gogo Inc in Q3 2025, an estimated $397K increase.
  • PharVision Advisers's biggest Q3 2025 reduction was Western Union, cutting an estimated $321K.
  • PharVision Advisers fully exited Cirrus Logic in Q3 2025, selling an estimated $563K.
  • PharVision Advisers's ten largest holdings make up 3.9% of its $178M portfolio in Q3 2025.
  • PharVision Advisers opened 562 new positions and closed 175 in Q3 2025.
  • PharVision Advisers's portfolio value rose 155% quarter-over-quarter to $178M.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.